Symmetry and Asymmetry in Medicinal Chemistry
A special issue of Symmetry (ISSN 2073-8994). This special issue belongs to the section "Chemistry: Symmetry/Asymmetry".
Deadline for manuscript submissions: 28 February 2025 | Viewed by 15286
Special Issue Editor
2. Regional Centre of Advanced Technologies and Materials, Palacky University, Olomouc, Czech Republic
Interests: medicinal chemistry; drug design; structure–activity relationships; pharmaceutical analysis; ADME; nanoparticles; nanoformulations; controlled/targeted delivery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Symmetry, and, on the other hand, asymmetry (chirality), is one of the most important phenomena in nature, causing the uniqueness of life and life processes. Chirality is caused by a so-called chirality element in the structure of a molecule, which can be center (chiral atom), axis (with limited rotation around a simple bond), or plane. Any organism can be considered a chiral environment, and due to this phenomenon, it is possible to specifically influence the binding of biologically active compounds to their target sites, if their effect depends on the specific binding to the target organ.
The effect of diastereoisomers and even individual enantiomers can be completely different or even toxic. For this reason, in the last few decades, increased attention has been paid to the investigation of these optically active forms both in terms of binding to target sites and the detailed knowledge of the mechanism of action, including the structure of target sites and pharmacokinetic profile, i.e., bioavailability for target sites and affinity for metabolism at the formation of potentially toxic chiral metabolites.
This Special Issue “Symmetry and Asymmetry in Medicinal Chemistry” of the journal Symmetry will focus on recent activities in the investigation of bioactive compounds in all areas of medicinal chemistry. Therefore, we are looking for contributions (research and review articles) covering a wide range of topics on the asymmetry of bioactive compounds, including (though not limited to) the following:
- Asymmetric synthesis
- Chiral separation
- Analytical techniques suitable for the study of chiral compounds
- Structural characterization of receptors, enzymes, and other chiral targets of bioactive agents
- In silico study of chiral compounds
- In vitro/in vivo studies of chiral compounds
- Role of asymmetry in nanosciences
- Legislation and guidelines relating to the issue of chirality
Submit your paper and select the Journal “Symmetry” and the Special Issue “Symmetry and Asymmetry in Medicinal Chemistry” via: MDPI submission system. Our papers will be published on a rolling basis and we will be pleased to receive your submission once you have finished it.
Prof. Dr. Josef Jampilek
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Symmetry is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Chirality
- Drugs
- Natural compounds
- Synthesis
- Analysis
- Pharmacophore
- Targets
- In silico/in vitro/in vivo studies
- Asymmetry in nanosciences
- Legislation and guidelines
- Chemical biology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
Planned Papers
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
Title: Enantiomeric composition of 1-octen-3-yl acetate in essential oils
Authors: Justína Čuchorová; Júlia Peterková; Jaroslav Blaško; Róbert Kubinec
Affiliation: 1 Faculty of Natural Science, Comenius University, Bratislava, Slovakia
2 Axxence Slovakia s.r.o., Bratislava, Slovakia
Abstract: This study investigates the presence and enantiomeric composition of 1-octen-3-yl acetate in various essential oils (EOs), with a focus on lavender oil. The high commercial demand for EOs necessitates reliable methods to ensure their authenticity and quality due to the prevalence of sophisticated adulteration techniques. The study used natural 1-octen-3-yl acetate from Axxence Slovakia, with a purity of 99 %+, as an analytical standard. Samples of essential oils, including basil, bergamot, cardamom, coriander, eucalyptus, geranium, grapefruit, clove, lemon, lavender, cinnamon, wild orange, oregano, peppermint, Siberian fir, spearmint, tea tree, and thyme, were obtained from various producers. Gas chromatography-mass spectrometry (GC-MS) and gas chromatography with flame ionization detection (GC-FID) were used for qualitative and chiral analysis, respectively. GC-MS analysis identified the presence of 1-octen-3-yl acetate primarily in lavender essential oils. The concentration of this compound varied among samples from different producers, highlighting differences in the lavender species, geographical locations, and extraction methods used. Chiral analysis using GC-FID revealed differences in the enantiomeric ratios of 1-octen-3-yl acetate in the lavender oils. The natural standard showed a high enantiomeric purity with 97 % (R)-1-octen-3-yl acetate and 3 % (S)-1-octen-3-yl acetate. Samples from Doterra closely matched the standard, while those from other producers exhibited varying enantiomeric compositions, suggesting potential variations in production processes and geographical locations. The variability in the concentration and enantiomeric composition of 1-octen-3-yl acetate among different lavender oils underscores the importance of advanced analytical techniques in verifying the authenticity of essential oils. Chiral analysis is particularly valuable for detecting synthetic adulterants and ensuring the quality of natural EOs